2-[(3-硝基苯氧基)甲基]环氧乙烷 | 5332-66-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-[(3-硝基苯氧基)甲基]环氧乙烷
• 英文名称: Glycidyl m-nitrophenyl ether
• 英文别名: (RS)-1,2-epoxy-3-(3-nitrophenoxy)propane；2-((3-nitrophenoxy)methyl)oxirane；1-(2,3-epoxy-propoxy)-3-nitro-benzene；1-(2,3-Epoxy-propoxy)-3-nitro-benzol；1-(3-nitrophenoxy)-2,3-epoxypropane；2-[(3-Nitrophenoxy)methyl]oxirane
• CAS: 5332-66-1
• 化学式: C₉H₉NO₄
• mdl: MFCD00225414
• 分子量: 195.175
• InChiKey: CNJLXLVVZBTEOC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  67.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2910900090

反应信息

• 作为反应物：
  描述：

  2-[(3-硝基苯氧基)甲基]环氧乙烷 在 palladium on activated charcoal 硫酸 、 氢气 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 17.0h， 生成 N-[3-(3-ethoxy-2-hydroxypropoxy)phenyl]-3-methylsulfanylpropanamide
  参考文献：
  名称：

  Synthesis and Antiallergic Activity of Dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-Toluenesulfonate Derivatives

  摘要：

  The derivatives of dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-toluenesulfonates were synthesized and evaluated for antiallergic activity. The 2,3-dihydroxyethoxy group was introduced to the phenyl ring from the standpoint of lipophilicity and electronic effects of substituent. The IgE-induced rat passive cutaneous anaphylaxis (PCA) was inhibited by oral administration of several substituted 2-[(4-propoxyphenyl)carbamoyl]ethyldimethylsulfonium p-toluenesulfonate derivatives. Among them (+/-)-2-[4-(3-ethoxy-2-hydroxypropoxy)phenyl]-carbamoyl]ethyldimethylsulfonium p-toluenesulfonate (1a, IPD-1151T) was found to possess considerable activity in the PCA test, and it was launched as Suplatast tosilate in Japan.

  DOI：

  10.1021/jm970285z
• 作为产物：
  描述：

  glycidyl nosylate 在 potassium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 24.0h， 以58%的产率得到2-[(3-硝基苯氧基)甲基]环氧乙烷
  参考文献：
  名称：

  通过环氧乙烷-2-基甲基苯磺酸盐的意外重排合成2-（苯氧基甲基）环氧乙烷衍生物

  摘要：

  摘要 通过碱促进重排，从环氧乙烷-2-基甲基苯磺酸盐合成 2-(苯氧基甲基) 环氧乙烷衍生物。通过这个过程，随着 CS 键的意外断裂，形成了一个新的 CO 键。这种不寻常的反应具有反应条件温和、效率高和官能团耐受性优异的特点。在实验结果和对照实验的基础上提出了一个合理的反应机理。图形概要

  DOI：

  10.1080/00397911.2016.1258579

文献信息

• An Unusual (R)-Selective Epoxide Hydrolase with High Activity for Facile Preparation of Enantiopure Glycidyl Ethers
  作者：Jing Zhao、Yan-Yan Chu、Ai-Tao Li、Xin Ju、Xu-Dong Kong、Jiang Pan、Yun Tang、Jian-He Xu

  DOI：10.1002/adsc.201100031

  日期：2011.6

  ortho‐substituted phenyl glycidyl ethers and para‐nitrostyrene oxide. Worthy of note is that the substrate structure remarkably affected the enantioselectivities of the enzyme, as a reversed (S)‐enantiopreference was unexpectedly observed for the ortho‐nitrophenyl glycidyl ether. As a proof‐of‐concept, five enantiopure epoxides (>99% ee) were obtained in high yields, and a gram‐scale preparation of

  从巨大芽孢杆菌ECU1001中克隆了一种新的环氧水解酶（BMEH），该酶具有异常的（R）-对映体选择性和很高的活性。在对位取代的苯基缩水甘油醚和对硝基苯乙烯氧化物的生物拆分中，实现了最高的对映选择性（E > 200）。值得一提的是，底物结构显着影响了酶的对映选择性，因为人们意外地观察到邻硝基硝基苯缩水甘油醚的反向（S）-对映体选择性。作为概念验证，以高收率获得了五种对映纯环氧化合物（> 99％ee），并以克级制备了（S） -邻甲基苯基缩水甘油基醚，然后成功地在几个小时内完成，这表明BMEH为光学活性的环氧化物的高效制备有吸引力的生物催化剂。
• A Novel Method for Synthesis of Aryl Glycidyl Ethers
  作者：Zhen-Zhong Liu、Heng-Chang Chen、Sheng-Li Cao、Run-Tao Li

  DOI：10.1080/00397919408011305

  日期：1994.3

  Abstract A solid-liquid phase-transfer catalytic method for the synthesis of aryl glycidyl ethers has been described, and the factors affecting the reaction yield have been examined.

  摘要 描述了一种合成芳基缩水甘油醚的固液相转移催化方法，并考察了影响反应收率的因素。
• Synthesis and Structure-Activity Relationship of Some New β-Blocking Agents with Possible α-Adrenoreceptor Activity
  作者：JáNos Bergmann、KáLmáN Takács

  DOI：10.1002/ardp.19903230703

  日期：——

  A series of new phenoxypropanolamines with cyclic guanidine and isothiourea moieties has been prepared and investigated for non‐specific α‐ and α‐adrenoreceptor activity by receptor binding experiments on crude rat brain membrane. Some of them [9a, 10c] possess affinity for both β‐ and α‐adrenoreceptors.

  已经制备了一系列具有环状胍和异硫脲部分的新型苯氧基丙醇胺，并通过在大鼠粗脑膜上的受体结合实验研究了非特异性 α- 和 α- 肾上腺素受体活性。其中一些 [9a, 10c] 对 β- 和 α- 肾上腺素受体都有亲和力。
• Phenoxypropanolamine therapeutic agents
  申请人：Pfizer Inc.

  公开号：US03961072A1

  公开（公告）日：1976-06-01

  A series of novel substituted phenoxypropylamine derivatives have been prepared by reacting the appropriate 1-phenoxy-2,3-epoxypropane compound with a suitable organic amine reagent. The resulting 1-phenoxy-3-alkylaminopropan-2-ols are useful in the field of chemotherapy as anti-angina agents. Preferred members include compounds having an acetamido group substituted on the phenyl ring of the phenoxy moiety. Alternate methods of preparation are also provided.

  一系列新型的取代苯氧丙胺衍生物已经通过将适当的1-苯氧基-2,3-环氧丙烷化合物与适当的有机胺试剂反应而制备出来。所得的1-苯氧基-3-烷基氨丙醇在化疗领域中作为抗心绞痛剂是有用的。首选成员包括在苯氧基部分的苯环上取代有乙酰胺基团的化合物。另外提供了其他制备方法。
• Ph-dependent nmda receptor antagonists
  申请人：——

  公开号：US20040138502A1

  公开（公告）日：2004-07-15

  NMDA receptor blockers, including pH-sensitive NMDA receptor blockers, are provided as neuroprotective drugs that are useful in stroke, traumatic brain injury, epilepsy, and other neurologic events that involve acidification of brain or spinal cord tissue. Compositions and methods of this invention are used for treating neurodegeneration resulting from NMDA receptor activation. The compounds described herein have enhanced activity in brain tissue having lower-than normal pH due to pathological conditions such as hypoxia resulting from stroke, traumatic brain injury, global ischemia tat may occur during cardiac surgery, hypoxia tat may occur following cessation of breathing, pre-eclampsia, spinal cord trauma, epilepsy, chronic pain, vascular dementia and glioma tumors. Compounds described herein are also useful in preventing neurodegeneration in patients with Parkinson's Alzheimer's, Huntington's chorea, ALS, and other neurodegenerative conditions known to the art to be responsive to treatment using NMDA receptor blockers. Preferably the compounds provided herein are allosteric NMDA inhibitors.

  NMDA受体阻滞剂，包括pH敏感的NMDA受体阻滞剂，被提供作为神经保护药物，可用于中风、创伤性脑损伤、癫痫和其他涉及大脑或脊髓组织酸化的神经事件。本发明的组合物和方法用于治疗由NMDA受体激活引起的神经退行性疾病。所述化合物在具有低于正常pH的脑组织中具有增强的活性，这是由于病理条件（如中风引起的低氧血症、创伤性脑损伤、在心脏手术期间可能发生的全局缺血、呼吸停止后可能发生的低氧血症、妊娠期高血压综合症、脊髓损伤、癫痫、慢性疼痛、血管性痴呆和胶质瘤等）。所述化合物也可用于预防帕金森病、阿尔茨海默病、亨廷顿舞蹈症、肌萎缩侧索硬化症和其他已知对使用NMDA受体阻滞剂治疗有反应的神经退行性疾病患者的神经退行性。优选地，本文提供的化合物是变构NMDA抑制剂。